Atrial fibrillation, hypertension, and the cerebral vasodilatory reserve

Takayuki Katayama1, Kae Takahashi2, Osamu Yahara2

  • 1Department of Neurology, Asahikawa City Hospital, Asahikawa, Japan. katataka@gmail.com.

Insights

This study presents a cascade model linking atrial fibrillation and hypertension to reduced cerebral vasodilatory reserve and cognitive decline. Understanding this pathway is crucial for managing cardiovascular and neurological health.

Area of Science:

  • Cardiovascular Science
  • Neurology
  • Gerontology

Background:

  • Atrial fibrillation and hypertension are common cardiovascular conditions.
  • Cognitive decline is a significant health concern, particularly in aging populations.
  • The relationship between cardiovascular health and brain function is complex and multifactorial.

Purpose of the Study:

  • To propose a schematic cascade model.
  • To illustrate the interconnectedness of atrial fibrillation, hypertension, cerebral vasodilatory reserve, and cognitive decline.
  • To provide a framework for understanding disease progression and potential interventions.

Main Methods:

  • Conceptual modeling based on existing literature.
  • Integration of physiological pathways.
  • Graphical representation of proposed relationships.

Main Results:

  • A cascade model was developed, illustrating a potential pathway.
  • The model links atrial fibrillation and hypertension to impaired cerebral vasodilatory reserve.
  • This impairment is hypothesized to contribute to cognitive decline.

Conclusions:

  • The proposed cascade model offers a new perspective on the pathophysiology linking cardiovascular disease to cognitive impairment.
  • Further research is warranted to validate this model and explore therapeutic targets.
  • This framework may aid in developing strategies to prevent or mitigate cognitive decline in patients with cardiovascular conditions.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
503
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
619
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
611